These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28586471)

  • 1. Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis.
    Bürkner PC; Williams DR; Simmons TC; Woolley JD
    Schizophr Bull; 2017 Oct; 43(6):1291-1303. PubMed ID: 28586471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous oxytocin levels are associated with impaired social cognition and neurocognition in schizophrenia.
    Strauss GP; Chapman HC; Keller WR; Koenig JI; Gold JM; Carpenter WT; Buchanan RW
    J Psychiatr Res; 2019 May; 112():38-43. PubMed ID: 30849617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal oxytocin, social cognition and neurodevelopmental disorders: A meta-analysis.
    Keech B; Crowe S; Hocking DR
    Psychoneuroendocrinology; 2018 Jan; 87():9-19. PubMed ID: 29032324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.
    Pedersen CA; Gibson CM; Rau SW; Salimi K; Smedley KL; Casey RL; Leserman J; Jarskog LF; Penn DL
    Schizophr Res; 2011 Oct; 132(1):50-3. PubMed ID: 21840177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intranasal oxytocin on neurocognition in people with schizophrenia: A randomized controlled trial.
    İmamoğlu A; Stiles BJ; Jarskog LF; Pedersen CA; Elliott T; Penn DL
    J Psychiatr Res; 2024 Mar; 171():95-98. PubMed ID: 38262165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intranasal oxytocin on symptoms of schizophrenia: A multivariate Bayesian meta-analysis.
    Williams DR; Bürkner PC
    Psychoneuroendocrinology; 2017 Jan; 75():141-151. PubMed ID: 27825069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of oxytocin and vasopressin plasma levels with neurocognitive, social cognitive and meta cognitive function in schizophrenia.
    Aydın O; Lysaker PH; Balıkçı K; Ünal-Aydın P; Esen-Danacı A
    Psychiatry Res; 2018 Dec; 270():1010-1016. PubMed ID: 29609987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxytocin-augmented social cognitive skills training in schizophrenia.
    Davis MC; Green MF; Lee J; Horan WP; Senturk D; Clarke AD; Marder SR
    Neuropsychopharmacology; 2014 Aug; 39(9):2070-7. PubMed ID: 24637803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
    Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower- and Higher-Level Social Cognitive Factors Across Individuals With Schizophrenia Spectrum Disorders and Healthy Controls: Relationship With Neurocognition and Functional Outcome.
    Oliver LD; Haltigan JD; Gold JM; Foussias G; DeRosse P; Buchanan RW; Malhotra AK; Voineskos AN;
    Schizophr Bull; 2019 Apr; 45(3):629-638. PubMed ID: 30107517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal Oxytocin for Negative Symptoms of Schizophrenia: Systematic Review, Meta-Analysis, and Dose-Response Meta-Analysis of Randomized Controlled Trials.
    Sabe M; Zhao N; Crippa A; Strauss GP; Kaiser S
    Int J Neuropsychopharmacol; 2021 Aug; 24(8):601-614. PubMed ID: 33890987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of single dose intranasal oxytocin on social cognition in schizophrenia.
    Davis MC; Lee J; Horan WP; Clarke AD; McGee MR; Green MF; Marder SR
    Schizophr Res; 2013 Jul; 147(2-3):393-7. PubMed ID: 23676253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin administration enhances controlled social cognition in patients with schizophrenia.
    Woolley JD; Chuang B; Lam O; Lai W; O'Donovan A; Rankin KP; Mathalon DH; Vinogradov S
    Psychoneuroendocrinology; 2014 Sep; 47():116-25. PubMed ID: 25001961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
    Lee MR; Wehring HJ; McMahon RP; Liu F; Linthicum J; Verbalis JG; Buchanan RW; Strauss GP; Rubin LH; Kelly DL
    Schizophr Res; 2016 Apr; 172(1-3):165-8. PubMed ID: 26879587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin system dysfunction as a common mechanism underlying metabolic syndrome and psychiatric symptoms in schizophrenia and bipolar disorders.
    Quintana DS; Dieset I; Elvsåshagen T; Westlye LT; Andreassen OA
    Front Neuroendocrinol; 2017 Apr; 45():1-10. PubMed ID: 28049009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial.
    Halverson T; Jarskog LF; Pedersen C; Penn D
    Schizophr Res; 2019 Feb; 204():178-182. PubMed ID: 30243853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder.
    Greene RK; Spanos M; Alderman C; Walsh E; Bizzell J; Mosner MG; Kinard JL; Stuber GD; Chandrasekhar T; Politte LC; Sikich L; Dichter GS
    J Neurodev Disord; 2018 Mar; 10(1):12. PubMed ID: 29587625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent effects of oxytocin on "mind-reading" in healthy males.
    Macchia A; Zebhauser PT; Salcedo S; Burum B; Gold E; Alonso-Alonso M; Pascual-Leone A; Gilbert D; Brem AK
    Cogn Affect Behav Neurosci; 2022 Feb; 22(1):112-122. PubMed ID: 34519018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intranasal oxytocin in food intake and craving: A meta-analysis of clinical trials.
    Chen CY; Chiang YC; Kuo TC; Tam KW; Loh EW
    Clin Nutr; 2021 Oct; 40(10):5407-5416. PubMed ID: 34600216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary evidence that oxytocin does not improve mentalizing in women with schizophrenia.
    Bradley ER; Tai M; Hankin M; Woolley JD
    Horm Behav; 2021 Feb; 128():104915. PubMed ID: 33340522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.